维普中文期刊产品整合服务

Management of non-alcoholic fatty liver disease in 2015

查看全文 作  者:Neel [1]Malhotra;Melanie D [1,2]Beaton 高影响力作者 机构地区:[1]Department of Medicine,Division of Gastroenterology, Western University;[2]London Health Sciences Centre, University Hospital高影响力机构 出  处:《World Journal of Hepatology》索引2015年第7卷第30期,共6页高影响力期刊 摘  要:There is no single pharmacologic therapy that has been approved to treat nonalcoholic fatty liver disease in the general population. The backbone of therapy currently includes intensive lifestyle modification withestablished targets for diet and weight loss. The use of unsweetened, unfiltered coffee along with limiting high fructose corn syrup have emerged as beneficial dietary recommendations. The use of empiric oral hypoglycemic agents and vitamin E, however, has not been widely accepted. Developing bariatric surgical techniques are promising, but additional studies with long-term follow up are needed before it can be widely recommended. Finally, liver transplantation is an increasingly frequent consideration once complications of endstage disease have developed. The future treatment of those with nonalcoholic fatty liver disease will likely involve a personalized approach. The importance of the gut microbiome in mediating hepatocyte inflammation and intestinal permeability is emerging and may offer avenues for novel treatment. The study of anti-fibrotic agents such as pentoxifylline and FXR agonists hold promise and new pathways, such as hepatocyte cannabinoid receptor antagonists are being studied. With the incidence of obesity and the metabolic syndrome increasing throughout the developed world, the future will continue to focus on finding novel agents and new applications of existing therapies to help prevent and to mediate the progression of nonalcoholic fatty liver disease. 关 键 词:LOBULAR inflammation Non-alcoholic fattyliver disease Non-alcoholic STEATOHEPATITIS Liver FIBROSIS
相关文献

参考文献(34)

引证文献(6)

耦合文献(11)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费